Answers are grounded in this paper and cite their sources.
Background/Objectives: Celiac disease (CD) is commonly diagnosed at younger ages but may also occur in older adults, in whom atypical or nonspecific presentations can delay recognition. This study aimed to evaluate the frequency of isolated IgG-class tTG/EMA positivity and histopathological findings potentially compatible with CD in individuals aged 60 years and older and to describe the available demographic and laboratory characteristics of patients with these findings. Methods: This retrospective, single-center study included 742 unique patients aged ≥60 years who were evaluated at Giresun Training and Research Hospital between January 2022 and December 2024. Of these, 454 underwent duodenal biopsy, and 343 underwent celiac disease serological testing; 55 patients underwent both investigations and were therefore included in both test-specific groups. Age, sex, routine hematological and biochemical parameters, tissue transglutaminase antibodies (tTG), endomysial antibodies (EMA), Marsh classification, and histopathological findings were analyzed. All eligible patients were included, and no formal hypothesis testing was performed for the small groups with isolated IgG-class tTG/EMA positivity or histopathological findings potentially compatible with CD. Results: Isolated IgG-class tTG/EMA positivity was detected in 3 of 343 serologically evaluated patients (0.9%; 95% CI, 0.2–2.5%); no patients showed IgA-class tTG or EMA positivity. Histopathological findings potentially compatible with CD were identified in 8 of 454 patients who underwent duodenal biopsy (1.8%; 95% CI, 0.8–3.4%). Of these eight patients, six had nonspecific Marsh type 1 changes, and two had Marsh type 3b changes. Conclusions: Isolated IgG-class tTG/EMA positivity and histopathological findings potentially compatible with CD were identified among older adults undergoing routine clinical evaluation. However, nonspecific Marsh type 1 changes and the hospital-based study design preclude interpretation of these frequencies as confirmed CD prevalence. CD should therefore remain in the differential diagnosis of older adults when compatible clinical, serological, or histopathological findings are present.
No takes yet. Share an insight, caveat, or question.
Yavuz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: